Please login to the form below
J&J’s targeted bladder cancer treatment gets US approval
Balversa is first FGFR inhibitor
Sanofi joins Lilly in insulin price cut, but lawmakers have lost patience
Insulin price nearly tripled between 2002 and 2013
NICE says no to Novartis’ Kisqali combo in breast cancer
Double blow after Lilly rival recommended
Lynparza set for further expansion with EU approval in breast cancer
Companies have prostate cancer and pancreatic cancer in their sights
UniQure gets speedy US review for Huntington’s gene therapy
Pioneer gaining momentum again
Celgene files luspatercept ahead of key merger vote
Analysts predict peak revenues of $2bn
Teva’s migraine injection approved in Europe
Third anti-CGRP treatment to hit the market
AVEO warns EU approval of Fotivda could be at risk
Concerns arose with overall survival data
‘Post-Brexit landscape for EU-wide IP Rights: The Story So Far’
Brexit means pharma must review its intellectual property rights across Europe
-
Moving timesContinuity and stability are vital when it comes to the EMA's relocation when it leaves London
-
SMC gives green light for Amgen’s KyprolisThe committee also gives verdict on three other products
-
Gottlieb signs off with flair – and pledge of further drug price commentaryHighlights issues of insulin prices and competition
-
Merck bags Chinese OK for Keytruda in first-line lung cancerCountry has 782,000 new lung cancer cases each year
-
Call for temporary medicines export ban if no-deal Brexit strikesNHS could struggle to source medicines
-
UK business: Brexit deadlock causing “frustration and anger”Pharma must still plan for no-deal, only slightly later
-
NICE recommends MSD’s diabetes drug Steglatro
MSD offering lowest price to win share of SGLT-2 inhibitor market
-
FDA approves Novartis' next-gen MS drug MayzentDrug reduces risk of disease progression
-
Celgene hopes for second time lucky for ozanimod FDA filingOne of six key drugs for BMS-Celgene merger
Latest regulatory appointments
-
Professor Carole Longson moves from NICE to the ABPIShe joins the UK pharma body as its chief scientific officer
-
MedTech Europe appoints new board of directors
Chair of the board Michelle Brennan is among those newly elected
-
Greg Perry joins IFPMA as assistant director generalWill move to the global industry body from the Medicines Patent Pool
-
AVEO appoints Nikhil Mehta as its senior VP, regulatory and quality assurance
He joins the biopharma from Tang Capital Management
-
IFPMA names new communications director
Helen Gallagher joins the association from Ferring Pharmaceuticals
Featured jobs
- Experienced / Senior Account Director - Publications - London
-
Up to £80, 000 plus great benefits
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
- Project Manager - Digital Healthcare - London
-
Excellent Remuneration Package
- Account Director – London based Medical Communications Agency
-
Excellent Remuneration Package
- Editor – Medical Education Agency – Bucks
-
Salary TBC
- Senior / Principal Medical Writer - MedComms - Home Based / Vari...
-
Excellent Remuneration Packages
-
Director – Healthcare PR
-
Salary TBC
-
Senior Medical Writer
-
Salary TBC
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
- Senior Account Manager- Pharma and Life Scienes
-
Competitive salary and benefits
- Senior Account Director/ Associate Director- Pharma and Life Sci...
-
Competitive salary and benefits
-
Senior Medical Writer
-
Competitive salary and benefits
-
Account Director, Medical Education
-
Salary TBC
- Account Manager / Senior Account Manager - Healthcare Advertisin...
-
Excellent Remuneration
- Freelance Medical Writer - Healthcare Advertising - London
-
Employment Type:. Type of Job:. Region:. Salary:. 250 to 330 per day
- Project Manager - Medical Communications – South Wales
-
Excellent Remuneration Package
Subscribe to our email news alerts
- With Spiriva under pressure, Boehringer moves to bolster pipeline
- Genfit claims FDA breakthrough status for liver disease drug
- Mereo’s shareholders back OncoMed takeover
- Lucid Group announces the appointment of new CFO
- From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
- Q&A: Niels Lund
PMHub
Blue Latitude Health
Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...
Latest intelligence
- From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
- How pharma is progressing their commitment in patient engagement...
- Cuttsy+Cuttsy awarded CPD Platinum by the IPA
- Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
- Breaking Bad
- Six behaviours separate the good brand teams from the bad...
Quick links
Infographics
